Clinical Trials Directory

Trials / Completed

CompletedNCT00520962

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)

Status
Completed
Phase
Study type
Observational
Enrollment
1,997 (actual)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Accepted

Summary

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis. The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be \> 30 years, both gender.

Detailed description

The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.

Conditions

Timeline

Start date
1997-06-01
Completion
2006-05-01
First posted
2007-08-27
Last updated
2007-08-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00520962. Inclusion in this directory is not an endorsement.